about
Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.Field evaluation of an automated RDT reader and data management device for Plasmodium falciparum/Plasmodium vivax malaria in endemic areas of Colombia.Knowledge, attitudes and practices of malaria in Colombia.Protein identification in two phases of 1,3-propanediol production by proteomic analysis.Evaluation of the loop mediated isothermal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of ColombiaMultiplicity of Infection and Disease Severity in Plasmodium vivax.Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanusPlasmodium vivax gametocyte infectivity in sub-microscopic infections.Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over timeGlucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.Malaria elimination challenges in Mesoamerica: evidence of submicroscopic malaria reservoirs in Guatemala.Characterization of a malaria outbreak in Colombia in 2010.Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax.Characterizing the malaria rural-to-urban transmission interface: The importance of reactive case detection.Detection and quantification of Leishmania infantum in naturally and experimentally infected animal samples.Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.Langerhans Cells-Programmed by the Epidermis.Whole genome sequencing of field isolates reveals extensive genetic diversity in Plasmodium vivax from ColombiaMalaria systems immunology: Plasmodium vivax induces tolerance during primary infection through dysregulation of neutrophils and dendritic cellsConstitutive Activation of Natural Killer Cells in Primary Biliary CholangitisGenomic programming of IRF4-expressing human Langerhans cells
P50
Q30386746-AE88985D-A66D-4B22-AB46-77735C9D2FBCQ30773785-824FB8D6-5C7C-498A-BCD1-15BEDCEDB454Q33960100-FA811B58-6F62-41A8-A112-DB074E4E0EB1Q34786904-1D750BBD-967C-4B04-87A9-B0650C7F8DFDQ34875343-54028D91-57F2-4A55-A8CE-53423052F38BQ35890202-9C78D887-78D0-4136-B648-B716150559AEQ36063764-32F01F9D-FD9A-48BD-B5EA-9E090EA1BB59Q36513883-351CCB58-8AE1-4563-AB11-EFEB9E49A2A1Q36553405-598287B6-F9DB-4FFB-BE03-3534876B41BBQ36937236-4FD356F6-25C2-42C6-8FD5-2AA89A2AB37DQ37221275-F53A46C3-C002-4C93-8404-D5F1FF7576CBQ37359772-4564D009-0808-46F6-8FF7-AB4591CD7B1AQ37695945-4F02398A-EE70-4EB8-9D52-38B989DE1B53Q40120103-4885A57A-A2E8-4AAA-A485-C4397C2F0C35Q40579359-B89063BA-B694-4C05-8318-16CEB3F4CF84Q42428291-74FA26F9-6A18-4718-86C8-AF146186CA19Q47109271-D0F89536-C7FD-4921-A33F-E4671409102CQ57858932-358F4B11-3069-4248-9657-9702B38D6A10Q58702195-7D2185DA-2617-418A-B767-C34E2F43F881Q91707925-DE5D615B-7C56-43AA-8EAC-3255FC86627FQ92711520-3FE82518-62DF-443E-9F72-05F7F25F362B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrés F Vallejo
@ast
Andrés F Vallejo
@en
Andrés F Vallejo
@es
Andrés F Vallejo
@nl
Andrés F Vallejo
@sl
type
label
Andrés F Vallejo
@ast
Andrés F Vallejo
@en
Andrés F Vallejo
@es
Andrés F Vallejo
@nl
Andrés F Vallejo
@sl
prefLabel
Andrés F Vallejo
@ast
Andrés F Vallejo
@en
Andrés F Vallejo
@es
Andrés F Vallejo
@nl
Andrés F Vallejo
@sl
P106
P1153
55755387400
P21
P31
P496
0000-0002-4688-0598